| Literature DB >> 31065939 |
Nay Lin Tun1,2,3, Dong-Bao Hu4, Meng-Yuan Xia2, Dong-Dong Zhang1,2, Jun Yang2, Thaung Naing Oo5, Yue-Hu Wang6, Xue-Fei Yang7,8,9.
Abstract
We aimed at reporting the chemical constituents and antimicrobial activities of Leea aequata L., a traditional folk medicine used in Myanmar for the treatment of wounds and skin diseases. A new neolignan, (7S,8R)-9'-O-acetylcedrusin (1), a new lactam, (3S,4S)-4-chloro-3-hydroxypiperidin-2-one (2), along with 21 known compounds, including five lignans (3-7), four flavonoid glycosides (8-11), and others (12-23), were isolated from the ethanoic extract of the aerial parts of L. aequata. The structures of the new compounds were determined by NMR, MS, and ECD spectra. For all the antimicrobial tests of the 23 compounds, only 3,4,5-trihydroxybenzoic acid ethyl ester (17) showed weak inhibitory activities against Escherichia coli and Salmonella enterica subsp. enterica.Entities:
Keywords: Flavonoids; Leea aequata; Lignans; Traditional medicines; Vitaceae
Year: 2019 PMID: 31065939 PMCID: PMC6538738 DOI: 10.1007/s13659-019-0209-y
Source DB: PubMed Journal: Nat Prod Bioprospect ISSN: 2192-2209
Fig. 1Chemical structures of compounds 1–3 from Leea aequata
1H (800 MHz) and 13C NMR (200 MHz) data of 1 and 3 in CD3OD
| No. |
|
| ||
|---|---|---|---|---|
|
|
| |||
| 1 | 135.1 | 138.4 | ||
| 2 | 7.00 (d, 1.8) | 110.5 | 6.68 (d, 2.0) | 113.9 |
| 3 | 149.1 | 149.0 | ||
| 4 | 147.4 | 146.0 | ||
| 5 | 6.78 (d, 8.1) | 116.1 | 6.73 (d, 8.0) | 116.0 |
| 6 | 6.86 (dd, 8.1, 1.8) | 119.7 | 6.60 (dd, 8.0, 2.0) | 123.2 |
| 7 | 5.51 (d, 6.1) | 88.7 | 3.86 (d, 10.1) | 47.6 |
| 8 | 3.47 (m) | 55.7 | 1.79 (m) | 47.5 |
| 9 | 3.84 (m) | 65.1 | 3.60 (dd, 11.6, 3.3) | 61.6 |
| 3.77 (dd, 11.1, 7.3) | 3.39 (dd, 11.6, 3.6) | |||
| 1′ | 135.9 | 128.4 | ||
| 2′ | 6.58 (d, 1.2) | 117.0 | 6.65 (s) | 112.3 |
| 3′ | 142.0 | 147.3 | ||
| 4′ | 146.7 | 145.5 | ||
| 5′ | 129.9 | 6.19 (s) | 117.4 | |
| 6′ | 6.62 (br s) | 116.7 | 133.9 | |
| 7′ | 2.60 (2H, dd, 7.9, 7.1) | 32.8 | 2.82 (dd, 15.8, 4.7) | 33.5 |
| 2.75 (dd, 15.8, 10.5) | ||||
| 8′ | 1.92 (2H, m) | 31.7 | 2.22 (m) | 36.7 |
| 9′ | 4.07 (2H, td, 6.6, 1.0) | 65.1 | 4.26 (dd, 11.0, 4.2) | 68.2 |
| 4.11 (dd, 11.0, 7.2) | ||||
| 1″ | 173.1 | 173.2 | ||
| 2″ | 2.04 (3H, s) | 20.8 | 2.04 (3H, s) | 20.8 |
| 3-OMe | 3.84 (3H, s) | 56.4 | 3.78 (3H, s) | 56.4 |
| 3′-OMe | 3.80 (3H, s) | 56.4 | ||
Fig. 2Key 2D NMR correlations of compounds 1 and 2
1H (500 MHz) and 13C NMR (126 MHz) data of 2
| No. | ||||
|---|---|---|---|---|
|
|
| |||
| 2 | 169.5 | 172.5 | ||
| 3 | 3.78 (br d, 7.7) | 72.8 | 3.99 (d, 7.5) | 74.5 |
| 4 | 4.20 (ddd, 9.8, 7.7, 3.5) | 60.1 | 4.17 (ddd, 9.6, 7.5, 3.5) | 56.0 |
| 5β | 2.23 (m) | 29.2 | 2.38 (m) | 30.3 |
| 5α | 2.02 (m) | 2.12 (m) | ||
| 6 | 3.15 (2H, m) | 37.9 | 3.34 (2H, m) | 39.6 |
| 3-OH | 5.78 (br s) | |||
| NH | 7.68 (br s) | |||
Fig. 3Experimental and calculated ECD for compound 2